OptimizeRx Corp — Director's Dealing 2017

Apr 4, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2017-03-31

Reporting Person: BAKER DOUGLAS P (CHIEF FINANCIAL OFFICER)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-03-31	Stock Option	$0.82	A	200000	Acquired	2022-03-31	Common Stock (200000)	Direct
2017-03-31	Stock Option	$0.82	A	100000	Acquired	2022-03-31	Common Stock (100000)	Direct

Footnotes

F1: The Stock Options were issued based on performance criteria and only vest upon target revenue achieved in 2017.

F2: The Stock Options will vest as to 50% of the shares on September 30, 2017 and 50% of the shares on March 31, 2018.